TABLE OF CONTENTS
Volume 28, Issue 33 (20 August 2009)
Review
Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
A Satyanarayana and P Kaldis
Oncogene 28: 2925-2939; advance online publication, June 29, 2009; doi:10.1038/onc.2009.170
Original Articles
Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
N J Sullivan, A K Sasser, A E Axel, F Vesuna, V Raman, N Ramirez, T M Oberyszyn and B M Hall
Oncogene 28: 2940-2947; advance online publication, July 6, 2009; doi:10.1038/onc.2009.180
WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer
Y Li, Z Zhou, M Alimandi and C Chen
Oncogene 28: 2948-2958; advance online publication, June 29, 2009; doi:10.1038/onc.2009.162
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor
S Confalonieri, M Quarto, G Goisis, P Nuciforo, M Donzelli, G Jodice, G Pelosi, G Viale, S Pece and P P Di Fiore
Oncogene 28: 2959-2968; advance online publication, June 22, 2009; doi:10.1038/onc.2009.156
Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array
R Radpour, C Kohler, M M Haghighi, A X C Fan, W Holzgreve and X Y Zhong
Oncogene 28: 2969-2978; advance online publication, June 8, 2009; doi:10.1038/onc.2009.149
Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells
W Zhou, Y Tu, P J Simpson and F P Kuhajda
Oncogene 28: 2979-2987; advance online publication, June 22, 2009; doi:10.1038/onc.2009.160
RASSF2 associates with and stabilizes the proapoptotic kinase MST2
W N Cooper, L B Hesson, D Matallanas, A Dallol, A von Kriegsheim, R Ward, W Kolch and F Latif
Oncogene 28: 2988-2998; advance online publication, June 15, 2009; doi:10.1038/onc.2009.152
Short Communication
Dab2 stabilizes Axin and attenuates Wnt/
-catenin signaling by preventing protein phosphatase 1 (PP1)–Axin interactions
Y Jiang, W Luo and P H Howe
Oncogene 28: 2999-3007; advance online publication, July 6, 2009; doi:10.1038/onc.2009.157
Corrigenda
The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells FREE
M Kato, T Paranjape, R U Müller, S Nallur, E Gillespie, K Keane, A Esquela-Kerscher, J B Weidhaas and F J Slack
Oncogene 28: 3008; doi:10.1038/onc.2009.218
